Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines-Reference-Cited by-同舟云学术

Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines

Published:2024-05 Issue: Volume:65 Page:101180
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Mikulska Malgorzata,Oltolini Chiara,Zappulo Emanuela,Bartoletti Michele,Frustaci Anna Maria,Visentin Andrea,Vitale Candida,Mauro Francesca R.

Funder

AstraZeneca

Publisher

Elsevier BV

Reference117 articles.

1. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients;Teh;Lancet Infect Dis,2023

2. ESCMID study Group for Infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (intracellular signaling pathways: tyrosine kinase and mTOR inhibitors);Reinwald;Clin Microbiol Infect,2018

3. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European conference on infections in leukemia (ECIL);Maschmeyer;Leukemia,2019

4. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Eichhorst;Ann Oncol,2021

5. Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of infections for patient treated with ibrutinib in clinical practice;Frontiers in Oncology;2024-09-10